Dana J. Bolden

GSK Consumer Health Division: Senior Vice President, Global Corporate Affairs

Dana Bolden joined GSK Consumer Healthcare in January 2021 where he leads the Global Corporate Affairs function and sits on the “NewCo” executive committee.

Over the course of his 25-plus year career in corporate communications, Dana has been on the front-lines of leading and executing large-scale business development and strategic transformation efforts at some of the most powerful brands in the world, including  Philip Morris, The Coca-Cola Company, Corteva Agriscience and, currently, GSK’s consumer health division, which is slated to spin off from GSK (and rebrand) in the summer of 2022.

Prior to GSK, Dana served as Senior Vice President for External Affairs at Corteva Agriscience formerly the agriculture division of DowDuPont, where he has managed complex corporate affairs issues including a spin off and listing process. Prior to this, he worked for The Coca-Cola Company. He has a wealth of consumer and regulated industry experience working in-house and in agency having started his career at Cohn and Wolfe and has lived and worked in the United States, Europe, Africa and Asia. 

Bolden’s contributions to reputation management, enterprise strategy and the communication craft extend well beyond the corporate realm. He currently serves on the Board of Trustees for Washington & Lee and chairs the university’s Trusteeship Committee. He also serves on the College of Charleston’s Communications Advisory Council and lectures at his alma mater as well as several universities across the nation and the world. Additionally, he has a passion for raising funds for first-generation college student scholarships and for connecting people of color with corporate board service.